Table 3.
Management of thyroid storm in pregnant patients | |
---|---|
General measures | • Admit to ICU |
• Continuous cardiac and fetal monitoringa | |
• Emergent enteral and intravenous access | |
• Fluid resuscitation with crystalloids | |
• Correction of electrolyte abnormalities (e.g., hypokalemia) | |
• External cooling and antipyretic therapy to target euthermia (acetaminophen preferred over aspirin) | |
• Search for underlying etiology | |
• Avoid deliverya | |
Urgent | • Antithyroid medications |
1st line – PTU 600–1000 mg loading dose followed by 200–250 mg q4h | |
2nd line – MMI 20 mg q6h | |
• Steroids | |
Hydrocortisone (300 mg IV loading dose, then 100 mg IV q8h) (preferred over dexamethasonea) | |
• Beta blockers | |
1st line—Esmolol loading dose of 250–500 μg/kg IV over 30 s, followed by an infusion at 50–100 μg/kg/minute 2nd line – Propranolol enteral (60–80 mg q4-6 h) or IV (1 mg over 10 min) | |
Avoid atenolola | |
After 1 h | SSKI (5 drops or 250 mg q6-8 h) or Lugol’s iodine (10 drops or 0.5 mL q8h) (lithium carbonate contraindicatedª) |
Refractory thyroid storm | • Cholestyramine 4 g q6h |
• Plasmapheresis –place patient in left lateral position to avoid IVC compressiona | |
• Consider emergent thyroidectomy | |
After resolution | Continue PTU (if in the 1st trimester) or switch to MMI (if in the 2nd trimester)ª |
Continue to monitor for antithyroid medication toxicity |
PTU Propylthiouracil, MMI Methimazole, SSKI Saturated Solution of Potassium Iodide; q every, IVC Inferior vena cava, IV Intravenous, h hours
aSteps marked indicate the steps which are different from conventional management of thyroid storm in non-pregnant patients